Viking Therapeutics - About the company
Viking Therapeutics is a public company based in California (United States), founded in 2012. It operates as a Provider of small molecule therapies for endocrine and metabolic disorders. Viking Therapeutics has raised $2.5M in funding. The company has 45 active competitors, including 13 funded and 20 that have exited. Its top competitors include companies like Neurocrine, Crinetics and Carmot.
Company Details
Provider of small molecule therapies for endocrine and metabolic disorders. It has a portfolio of five therapeutic programs which are based on small molecules. Its lead product VK0612, an orally available drug candidate for type 2 diabetes. Its second lead product is VK5211, an orally available, non-steroidal selective androgen receptor modulator for the treatment of cancer cachexia. Additionally, it is developing three novel preclinical programs targeting metabolic diseases and anemia.
- Website
- Social
Key Metrics
Founded Year
2012
Location
California, United States
Stage
Public
Total Funding
in 1 round
Latest Funding Round
Investors
Ranked
14th among 45 active competitors
Employee Count
as on Dec 31, 2023
Similar Companies
Exit Details
Public
Legal entities associated with Viking Therapeutics
Viking Therapeutics is associated with 1 legal entity given below:
Legal Entity Name | Date of incorporation | Revenue | Net Profit | Employee Count |
|---|---|---|---|---|
Dec 26, 999 | - | 730 | 971 |
Viking Therapeutics's funding and investors
Viking Therapeutics has raised a total funding of $2.5M over 1 round. Its latest funding round was a Seed round on May 22, 2014 for $2.5M. 1 investor participated in its latest round, which include Primarius Capital, and Gynther Capital.
Viking Therapeutics has 3 institutional investors including , and .
Here is the list of recent funding rounds of Viking Therapeutics:
Date of funding | Funding Amount | Round Name | Post money valuation | Revenue multiple | Investors |
|---|---|---|---|---|---|
May 22, 2014 | $2.5M | Seed | 3311787 | 4628988 |
Access funding benchmarks and valuations. Sign up today!View details of Viking Therapeutics's funding rounds and investors
Viking Therapeutics's founders and board of directors
Viking Therapeutics's employee count trend
Viking Therapeutics has 27 employees as of Dec 23. The total employee count is 28.6% more than what it was in Dec 22. Here is Viking Therapeutics's employee count trend over the years:
Uncover Viking Therapeutics's growth story! Sign up today!Viking Therapeutics's Competitors and alternates
Top competitors of Viking Therapeutics include Neurocrine, Crinetics and Carmot. Here is the list of Top 10 competitors of Viking Therapeutics, ranked by ÃØÃÜÑо¿Ëù score :
Get insights and benchmarks for competitors of 2M+ companies! Sign up today!
Overall Rank | Company Details | Short Description | Total Funding | Investors | ÃØÃÜÑо¿Ëù Score |
|---|---|---|---|---|---|
1st | Neurocrine 1992, San Diego (United States), Public | Developer of small molecule therapeutics for endocrine and CNS disorders | $10M | Venrock, BB BiotechÌý&²¹³¾±è;Ìý | 74/100 |
2nd | Crinetics 2008, San Diego (United States), Public | Developer of therapies for the treatment of endocrine-related diseases and cancers | $104M | Frazier Healthcare Partners, Versant VenturesÌý&²¹³¾±è;Ìý | 73/100 |
3rd | Carmot 2008, Berkeley (United States), Acquired | Developer of disease-modifying therapies to treat metabolic diseases | $386M | Venrock, Frazier Healthcare PartnersÌý&²¹³¾±è;Ìý | 68/100 |
4th | Zucara Therapeutics 2015, Vancouver (Canada), Series B | Developing a long-term therapeutic approach to prevent hypoglycemia in patients with diabetes | $50.8M | , Ìý&²¹³¾±è;Ìý | 67/100 |
5th | Novo Nordisk 1923, Bagsvaerd (Denmark), Public | Manufacturer of drugs for diabetes, obesity, and hemophilia & hormone therapy | $145K | Tekla Capital Management, IFUÌý&²¹³¾±è;Ìý | 67/100 |
6th |  MBX Biosciences 2018, Carmel (United States), Public | Developer of drugs for the treatment of rare endocrine diseases | $216M | Frazier Healthcare Partners, OrbimedÌý&²¹³¾±è;Ìý | 66/100 |
7th | Zealand Pharma 1998, Glostrup (Denmark), Public | Developer of protein therapies for the treatment of diabetes and gastrointestinal diseases | - | Athyrium Capital Management, Idinvest PartnersÌý&²¹³¾±è;Ìý | 62/100 |
8th |  Metsera 2022, New York City (United States), Public | Biopharmaceutical company focusing on medicines for obesity and metabolic diseases | $505M | Venrock, T. Rowe PriceÌý&²¹³¾±è;Ìý | 58/100 |
9th |  Radionetics 2021, San Diego (United States), Series A | Developer of radiopharmaceuticals for cancer treatment | $137M | Frazier Healthcare Partners, 5AM VenturesÌý&²¹³¾±è;Ìý | 58/100 |
10th | Kailera 2024, Waltham (United States), Series A | Developer of therapies for treating obesity and related conditions | $400M | Atlas Venture, Bain Capital Life SciencesÌý&²¹³¾±è;Ìý | 57/100 |
14th | 2012, California (United States), Public | Provider of small molecule therapies for endocrine and metabolic disorders | $2.5M | Primarius Capital, Ìý&²¹³¾±è;Ìý | 47/100 |
Get insights and benchmarks for competitors of 2M+ companies! Sign up today!Looking for more details on Viking Therapeutics's competitors? Click to see the top ones
Viking Therapeutics's Investments and acquisitions
Viking Therapeutics has made no investments or acquisitions yet.
Reports related to Viking Therapeutics
Here is the latest report on Viking Therapeutics's sector:
View
News related to Viking Therapeutics
Media has covered Viking Therapeutics for a total of 58 events in the last 1 year, 43 of them have been about company updates and 2 about partnerships.
•
•
•
•
PR Newswire•Mar 26, 2025•Viking Therapeutics
•
•
•
•
•
•
Get curated news about company updates, funding rounds, M&A deals and others. Sign up today!Frequently asked questions about Viking Therapeutics
When was Viking Therapeutics founded?
Viking Therapeutics was founded in 2012.Where is Viking Therapeutics located?
Viking Therapeutics is located in California, United States.When was the latest funding round of Viking Therapeutics?
Viking Therapeutics's latest funding round was on May 22, 2014.What is the annual revenue of Viking Therapeutics?
Annual revenue of Viking Therapeutics is undefined as on undefined.Our Lite Plan Awaits you - Its Free!
Sign up now to unlock full access to curated data
4M+ Companies- 212K+ Investors
- 580K+ Funding Rounds
- 207K+ Acquisitions
- 2.9K+ Sectors
- 57K+ Business Models
Are you a Founder ?
Explore our recently published companies
- Fine Handling - 2008 founded, Unfunded company
- Pubcare - Fukuoka based, 2020 founded, Unfunded company
- Artesian Scrubbing Bubbles - Martinsville based, Unfunded company
- Three Point O Labs - Hyderabad based, 2022 founded, Unfunded company
- All Klaipeda Hotels - Klaipeda based, 2016 founded, Unfunded company
- Grandmas Jam House - 1995 founded, Unfunded company
